Episode 31: David Mitchell & Patients For Affordable Drugs episode artwork

EPISODE · May 8, 2018 · 28 MIN

Episode 31: David Mitchell & Patients For Affordable Drugs

from RealTalk MS · host Jon Strum

In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why my guest this week is David Mitchell, founder and president of Patients for Affordable Drugs.     We're also talking about the RealTalk MS Podcast Alexa Skill! If you already own an Amazon Echo, Dot, or any Alexa-enabled device, you can access all sorts of convenient features for listening to RealTalk MS! (And if you don't yet have an Alexa-enabled device, this might be one more reason to get one!)   A new study concludes that Autologous Haematopoietic Stem Cell Therapy is safe and effective in treating 'aggressive' MS. Another pilot study demonstrates that aspirin can help prevent the onset of overheating and exhaustion following exercise. And your future appointments with your neurologist just may take place from the comfort of your own home.   We have a lot to talk about! Are you ready for RealTalk MS? ____________ Our Alexa Announcement  :27 Study Shows Autologous Hematopoietic Stem Cell Therapy Safe & Effective In Treating "Aggressive" MS  4:40 Overheating When You Exercise? Study Recommends Taking 2 Aspirin  8:06 How About Having Your Next Appointment With Your Neurologist At Home?  10:15 Interview with David Mitchell  13:00 ___________ LINKSIf your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com The RealTalk MS Podcast Alexa Skill STUDY: Autologous Haematopoietic Stem Cell Transplantation in Treatment Naive Patients with 'Aggressive' Multiple Sclerosis STUDY: A Randomized Controlled Pilot Trial of Aspirin to Improve Exercise Performance in Persons with Multiple Sclerosis SURVEY: Telemedicine Reduces Barriers to Care for Patients with Multiple Sclerosis and Neruoinflammation Patients For Affordable Drugs Give RealTalk MS a Rating & Review ___________ Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 31 Guest: David Mitchell Hosted By: Jon Strum Tags: MS, multiple sclerosis, Alexa, David Mitchell, Patients for Affordable Drugs, aHSTC, Stem Cells, Telemedicine, RealTalk MS    

NOW PLAYING

Episode 31: David Mitchell & Patients For Affordable Drugs

0:00 28:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of RealTalk MS?

This episode is 28 minutes long.

When was this RealTalk MS episode published?

This episode was published on May 8, 2018.

What is this episode about?

In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why my guest this week is David Mitchell, founder and...

Can I download this RealTalk MS episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!